Hyperfractionated radiotherapy improves local-regional control without increasing late toxicity

Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study.

Medical Xpress